Coherus Biosciences (CHRS)

Coherus Biosciences (CHRS) Stock Price & Analysis


CHRS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$3.60 - $14.11
Previous Close$4.45
Average Volume (3M)1.84M
Market Cap
Enterprise Value$456.28M
Total Cash (Recent Filing)$128.09M
Total Debt (Recent Filing)$225.90M
Price to Earnings (P/E)-1.3
Aug 03, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.47
Shares Outstanding80,553,730
10 Day Avg. Volume3,456,599
30 Day Avg. Volume1,843,704
Standard Deviation0.17
Financial Highlights & Ratios
Price to Book (P/B)-1.63
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.02
Enterprise Value/Gross Profit-6.51
Enterprise Value/Ebitda-1.95
Price Target Upside235.73% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Coherus Biosciences’s price range in the past 12 months?
Coherus Biosciences lowest stock price was $3.60 and its highest was $14.11 in the past 12 months.
    What is Coherus Biosciences’s market cap?
    Currently, no data Available
    When is Coherus Biosciences’s upcoming earnings report date?
    Coherus Biosciences’s upcoming earnings report date is Aug 03, 2023 which is in 59 days.
      How were Coherus Biosciences’s earnings last quarter?
      Coherus Biosciences released its earnings results on May 08, 2023. The company reported -$0.96 earnings per share for the quarter, missing the consensus estimate of -$0.721 by -$0.239.
        Is Coherus Biosciences overvalued?
        According to Wall Street analysts Coherus Biosciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Coherus Biosciences pay dividends?
          Coherus Biosciences does not currently pay dividends.
          What is Coherus Biosciences’s EPS estimate?
          Coherus Biosciences’s EPS estimate is -$0.72.
            How many shares outstanding does Coherus Biosciences have?
            Coherus Biosciences has 80,553,730 shares outstanding.
              What happened to Coherus Biosciences’s price movement after its last earnings report?
              Coherus Biosciences reported an EPS of -$0.96 in its last earnings report, missing expectations of -$0.721. Following the earnings report the stock price went down -27.396%.
                Which hedge fund is a major shareholder of Coherus Biosciences?
                Among the largest hedge funds holding Coherus Biosciences’s share is Platinum Investment Management. It holds Coherus Biosciences’s shares valued at 4M.


                  Coherus Biosciences Stock Smart Score

                  The Coherus Biosciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Coherus Biosciences

                  Coherus BioSciences, Inc. is a commercial-stage clinical biologics platform company, which engages in the development and commercialization of biosimilar therapeutics. Its clinical products include pegfilgrastim biosimilar, adalimumab biosimilar, etanercept biosimilar, ranibizumab biosimilar, and aflibercept biosimilar. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.


                  Top 5 ETFs holding CHRS

                  Market Value
                  Smart Score
                  Vanguard Health Care ETF
                  iShares Core S&P Total U.S. Stock Market ETF
                  Middlefield Healthcare Dividend ETF Registered
                  Fidelity MSCI Health Care Index ETF
                  iShares NASDAQ US Biotechnology UCITS ETF
                  Up to five ETFs with an Outperform Smart Score that hold CHRS. The ETFs are listed according to market value of CHRS within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Kala Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis